DroneShield’s Maturity Status Can’t Stop the Bleeding as ASIC Probe Spooks Investors

DroneShield has just been handed a vote of confidence from the Australian Securities Exchange, but the market is paying it no mind. The ASX this week relieved the counter-drone specialist from its obligation to report quarterly cash-flow statements — a privilege reserved for companies with four straight quarters of positive operating cash flow and a balance sheet that no longer screams “speculative growth stock.” Yet the shares have done nothing but slide, shedding 15% in the past seven days alone to close at €1.41 on Thursday.

The stock is now deep in oversold territory, with the relative strength index reading 23.8. It has lost 29% since the start of 2026 and trades more than 30% below its 200-day moving average. From its October 2025 peak of €3.65, the share price has collapsed 61%. The technical picture is ugly — and getting uglier.

What makes the selloff particularly jarring is that the fundamental backdrop has rarely looked stronger. DroneShield ended the first quarter with around 220 million Australian dollars in cash and no debt. Revenue surged 121% year-over-year to A$74 million, driven by booming global demand for airspace security and AI-powered detection systems. The operating cash flow turned positive for a fourth straight quarter, triggering the ASX’s reclassification.

The company is also scaling up fast. By the end of 2026, it aims to boost annual production capacity to A$2.4 billion. Its newly established European supply chain has already shipped its first units, and a local manufacturing hub in Europe is expected to slash delivery times for government and military contracts — particularly from NATO allies scrambling to upgrade their drone-defence and electronic-warfare capabilities.

Should investors sell immediately? Or is it worth buying DroneShield?

Europe is becoming a central pillar of the growth story. At the Eurosatory defence exhibition in June, DroneShield signed a memorandum of understanding with Dutch tactical-vehicle maker Defenture to integrate its counter-UAS systems onto platforms such as the Mammoth and the GRF. And it opened a European headquarters in Amsterdam, underscoring a long-term bet on sovereign counter-drone capacity in the region.

The boardroom is also being strengthened with military heft. Rear Admiral Lee Goddard CSC, the founding CEO of the Australian Missile Corporation and a 30-year veteran of defence and national security, will join as an independent non-executive director on July 1. Chairman Hamish McLennan called the appointment part of an ongoing board renewal process. Goddard’s presence should bolster DroneShield’s credibility with government buyers and export agencies — a crucial edge as it chases large-scale contracts.

So why is the market still selling? The primary overhang is an investigation launched by the Australian Securities and Investments Commission in May 2026. The probe has kept institutional investors on the sidelines, despite the operational strength. With a 30-day annualised volatility of around 53%, a regulatory cloud is enough to whip sentiment around. Even a record project pipeline of A$2.2 billion has failed to change the narrative.

DroneShield at a turning point? This analysis reveals what investors need to know now.

All eyes are now on August 26, when DroneShield is due to release its half-year results. The report will reveal how much of that pipeline — and the A$1.1 billion US-dollar-denominated order backlog noted in earlier filings — has actually turned into recognised revenue. If the conversion rate is strong, it may finally give the market the excuse it needs to look past the ASIC investigation and revalue the stock. Until then, the gap between operational momentum and share-price performance remains wide — and getting wider.

Ad

DroneShield Stock: New Analysis - 26 June

Fresh DroneShield information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated DroneShield analysis...

en | AU000000DRO2 | DRONESHIELD’S | boerse | 69628687 |